Eli Lilly & Company

Pharmaceutical/ Health Products

Based in DC

🤖

AI Overview

With $1.6M in lobbying spend across 32 quarterly filings, Eli Lilly & Company is a significant lobbying presence. They deploy 17 individual lobbyists Their lobbying covers 9 issue areas. Active from 2018 to 2025.

$1.6M
Total Spend
8
Years Active
1
Firms Hired
17
Lobbyists Deployed
9
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$200K
2019$200K
2020$200K
2021$200K
2022$200K
2023$200K
2024$200K
2025$200K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation, Defense and 4 more

  • Medicare Part D. CMMI Medicare Part B Demonstration, education about policies impacting reimbursement.
  • General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and counterfeiting; FDA user fees; H.R. 1628, American Health Care Act of 2017.
  • Policies impacting Medicare Part D, H.R. 1625, Consolidated Appropriations Act. H.R. 1892, the Bipartisan Budget Act of 2018.
  • International and domestic tax issues. Implementation of H.R. 1, Tax Cuts and Jobs Act.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.